SCHEMBL19798773

SCHEMBL19798773

Cc1cccc2c1N(C(C)C)c1c(C)cccc1S2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 5/20 0.34
PTGS1 P23219 3/20 0.33
MAOA P21397 3/20 0.33
PTGS2 P35354 2/20 0.33
CYP2D6 P10635 4/20 0.32
SCN4A P35499 3/20 0.32
LMNA P02545 3/20 0.32
SCN1A P35498 3/20 0.32
TSHR P16473 2/20 0.32
CYP1A2 P05177 2/20 0.32
HTR2A P28223 2/20 0.32
SLC6A4 P31645 2/20 0.32
HTR2B P41595 2/20 0.32
KCNH2 Q12809 2/20 0.32
SCN2A Q99250 2/20 0.32
SCN3A Q9NY46 2/20 0.32
SCN5A Q14524 2/20 0.32
SCN9A Q15858 2/20 0.32
MAOB P27338 1/20 0.32
NOX1 Q9Y5S8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28939779 0.90 TSHR (0.40) BCHEPTGS1LMNATSHRCYP1A2
SCHEMBL22600935 0.73 ALDH1A1 (0.34) TSHRCYP1A2ALDH1A1ALOX15MEN1
SCHEMBL5435400 0.73 BCHE (0.47) BCHECYP2D6TSHRHTR2AHTR2B
SCHEMBL19798774 0.72 KDM1A (0.37) BCHEPTGS1MAOAPTGS2CYP2D6
SCHEMBL22600834 0.72 MAPT (0.32) ALDH1A1
SCHEMBL19798777 0.71 BCHE (0.37) BCHEMAOALMNATSHRNOX1
SCHEMBL1720092 0.71 MAOA (0.50) BCHEPTGS1MAOAPTGS2SLC6A4
SCHEMBL2586864 0.69 MAOA (0.64) BCHEMAOALMNASLC6A4HTR2B
SCHEMBL23072132 0.68 MAOA (0.43) BCHEPTGS1MAOAPTGS2CYP2D6
SCHEMBL30184394 0.68 MAOA (0.58) BCHEPTGS1MAOAPTGS2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10854911-B2 1,9,10-substituted phenothiazine derivatives with strained radical cations and use thereof UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2020-12-01 US disclosed
US-20180026297-A1 1,9,10-SUBSTITUTED PHENATHIAZINE DERIVATIVES WITH STRAINED RADICAL CATIONS AND USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-01-25 US disclosed
US-20180026297-A1 1,9,10-SUBSTITUTED PHENATHIAZINE DERIVATIVES WITH STRAINED RADICAL CATIONS AND USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10854911-B2 1,9,10-substituted phenothiazine derivatives with strained radical cations and use thereof SLC6A9, PEX3, PAOX BCHE 4376/4885PTGS1 3618/4885MAOA 2172/4885
US-20180026297-A1 1,9,10-SUBSTITUTED PHENATHIAZINE DERIVATIVES WITH STRAINED RADICAL CATIONS AND USE THEREOF PFAS, SLC6A9, PEX3 BCHE 3640/4885PTGS1 2929/4885MAOA 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.